Eli Lilly and Company (LLY)
Summary
Looking to diversify away from AI trade? Buy these 3 stocks
For investors seeking to pare exposure to the artificial intelligence (AI) trade amid boom-induced volatility, shifting capital toward overlooked equities offers a compelling strategic alternative. Market participants are increasingly adopting a “defensive posture” against a possible downturn – pivoting to segments where high-quality operators with solid fundamentals have fallen out of favor leading to unwarranted valuation de-ratings.
Use These ETFs as Health Stocks LLY, UNH, MRK Thrive
Health stocks had a strong week, with some big firms seeing drugs approved. Eli Lilly (LLY) reportedly neared an agreement to acquire a psychedelics company.
Eli Lilly's $3.8bn psychedelics bet is built on British science
Eli Lilly's first venture into psychedelic medicine, a takeover of AtaiBeckley worth up to $3.8 billion, is above all a vindication of two decades of British research once dismissed as fringe science. The prize at the centre of the deal is BPL-003, a nasal spray formulation of the psychedelic compound 5-MeO-DMT developed by Beckley Psytech, the Oxford company founded by Amanda Feilding and her son Cosmo Feilding Mellen.
Eli Lilly and Company Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 23,156 | $17.57M | $26.51M | $8.94M | 50.92% |
| DI David Izzi Brown, LISLE/CUMMINGS Inc. | 3,320 | $1.66M | $3.8M | $2.14M | 129.44% |
| MSH Michelle S. Hickox FIRST FINANCIAL BANKSHARES Inc. | 897 | $571,452.35 | $1.03M | $455,621.62 | 79.73% |
| TMB Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 2,373 | $1.57M | $2.72M | $1.15M | 73.34% |
| LC Lisa Candera CIGNA INVESTMENTS Inc. /NEW | 7,641 | $1.22M | $8.75M | $7.53M | 615.73% |
Eli Lilly and Company Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TH Trung Huynh UBS | 27.42 | $33,333.33 | $32,171.16 | -$1,162.17 | -3.49% |
Eli Lilly and Company (LLY) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Eli Lilly and Company ever had a stock split?
Eli Lilly and Company Profile
| Pharmaceuticals Industry | Healthcare Sector | Mr. David A. Ricks CEO | NYSE Exchange | 532457108 CUSIP |
| BR Country | 50,000 Employees | 14 Aug 2026 Last Dividend | 16 Oct 1997 Last Split | 13 Jan 1978 IPO Date |
Overview
Eli Lilly and Company is a global leader in the discovery, development, and marketing of human pharmaceuticals. With a history dating back to 1876, the company has established itself as a key player in the pharmaceutical industry, offering a wide range of products aimed at treating a variety of conditions. Headquartered in Indianapolis, Indiana, Eli Lilly and Company has forged multiple collaborations with other pharmaceutical giants such as Incyte Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, Genentech, Inc., Biologics, Inc., AbCellera Biologics Inc., and Chugai Pharmaceutical Co., Ltd., enhancing its product offerings and research capabilities across different therapeutic areas.
Products and Services
- Diabetes Care
Includes a comprehensive portfolio of insulin and other diabetes treatments: Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500. Additionally, the company offers Jardiance, Mounjaro, and Trulicity for managing type 2 diabetes.
- Oncology
Provides a range of products for cancer treatment, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio, focusing on different types of cancer and treatment approaches.
- Immunology
Olumiant is offered for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19. Taltz is available for treating plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis.
- Digestive Diseases
Omvoh is targeted at ulcerative colitis, reflecting the company's commitment to addressing gastrointestinal disorders.
- Neurological Disorders
Includes Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain. Emgality is provided for migraine prevention and treatment of episodic cluster headache.
- Other Therapeutic Areas
The company also offers Cialis for erectile dysfunction and benign prostatic hyperplasia; Forteo for osteoporosis treatment; Zepbound for obesity management; and Ebglyss for severe atopic dermatitis, showcasing Eli Lilly's diverse portfolio catering to various health conditions.
